President’s Conversation

How is COVID-19 changing science? Join the conversation.

Join Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair, on Friday, September 25, from noon to 1 p.m. PDT for a President's Conversation about the dramatic ways COVID-19 is changing science — and not just for researchers focused on the coronavirus.

Please RSVP by September 24. After you register, you will receive instructions for how to join the conversation by computer, tablet, or phone. 

Date:
Friday, September 25, 2020
Location:
Virtual
Speaker or Presenter:
Dr. Lynch will lead a discussion with Drs. Jesse Bloom, Neel Dey, and Ruth Etzioni

Topics and Details

  • Open science is flourishing as researchers share their findings online in real time. 
  • Public interest in scientific research, and how it impacts our daily lives, is skyrocketing.
  • Social distancing is changing the way scientists work — in the lab, the clinic, and the community.

Dr. Lynch will lead a discussion with Drs. Jesse Bloom, Neel Dey, and Ruth Etzioni about these and other new realities scientists are navigating. We'll leave plenty of time to answer your questions.

Dr. Jesse Bloom is an evolutionary biologist and mathematician whose innovative tools are enabling scientists everywhere to understand the immune system’s response to the coronavirus and project how the virus could adapt to escape detection. This work is informing development of drugs and vaccines to fight COVID-19.

Dr. Neel Dey is a physician-researcher who studies how a person’s gut microbiome affects their risk for colorectal cancer. He has extended his research to explore whether strategies that target the microbiome can help patients recover from COVID-19 more quickly.

Dr. Ruth Etzioni, who holds the Rosalie and Harold Rea Brown Endowed Chair, is a biostatistician who primarily focuses on cancer screening and early detection. She has played a prominent role in the national conversation about the value and limitations of models for COVID-19 and other diseases.


We look forward to an engaging conversation!